A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cancer Research UK
Related studies linked through entity extraction aliases.
Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Extending the National Health Service (NHS) Breast Screening Age Range
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1
AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of OXi4503 (a Vascular Disrupting Agent) Given by 3 x Weekly Intravenous Infusions to Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer
- Status
- UNKNOWN
- Phase
- NA
Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
- Status
- UNKNOWN
- Phase
- N/A
Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer
- Status
- UNKNOWN
- Phase
- N/A
Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease
- Status
- UNKNOWN
- Phase
- PHASE2
Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends
- Status
- UNKNOWN
- Phase
- N/A
Study of DMXAA (Now Known as ASA404) in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1